{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:37Z","timestamp":1786982137427,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11916-022-01071-5","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T12:02:46Z","timestamp":1657108966000},"page":"693-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Infusion Therapy in the Treatment of Neuropathic Pain"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-7281","authenticated-orcid":false,"given":"Preston R.","family":"McMullin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Thomas","family":"Hynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ahnaf","family":"Arefin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moawiz","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvani","family":"Gandhavadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuha","family":"Arefin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim S.","family":"Eckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"1071_CR1","unstructured":"Terminology: International association for the study of pain. In: International Association for the Study of Pain (IASP). 2022.https:\/\/www.iasp-pain.org\/resources\/terminology\/. Accessed 21 January 2022."},{"key":"1071_CR2","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain Nat Rev Dis Primer. 2017;3:17002.","journal-title":"Neuropathic pain Nat Rev Dis Primer"},{"key":"1071_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3111\/13696998.2012.729548","volume":"16","author":"PC Langley","year":"2013","unstructured":"Langley PC, Van Litsenburg C, Cappelleri JC, Carroll D. The burden associated with neuropathic pain in Western Europe. J Med Econ. 2013;16:85\u201395.","journal-title":"J Med Econ"},{"key":"1071_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1503\/cmaj.060146","volume":"175","author":"I Gilron","year":"2006","unstructured":"Gilron I, Watson CPN, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician. CMAJ Can Med Assoc J. 2006;175:265\u201375.","journal-title":"CMAJ Can Med Assoc J"},{"key":"1071_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1752-9824.2011.01121.x","volume":"3","author":"M Lonnstedt","year":"2011","unstructured":"Lonnstedt M, Hackter Stahl C, Hedman AMR. Living with long-lasting pain - patients\u2019 experiences of neuropathic pain. J Nurs Health Chronic Illn. 2011;3:469\u201375.","journal-title":"J Nurs Health Chronic Illn"},{"key":"1071_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","volume":"160","author":"J Scholz","year":"2019","unstructured":"Scholz J, Finnerup NB, Attal N, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160:53\u20139.","journal-title":"Pain"},{"key":"1071_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11:521\u201334.","journal-title":"Lancet Neurol"},{"key":"1071_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1055\/s-0036-1584950","volume":"36","author":"J Gierthm\u00fchlen","year":"2016","unstructured":"Gierthm\u00fchlen J, Baron R. Neuropathic pain. Semin Neurol. 2016;36:462\u20138.","journal-title":"Semin Neurol"},{"key":"1071_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.mayocp.2015.01.018","volume":"90","author":"I Gilron","year":"2015","unstructured":"Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc. 2015;90:532\u201345.","journal-title":"Mayo Clin Proc"},{"key":"1071_CR10","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S1474-4422(13)70193-5","volume":"12","author":"I Gilron","year":"2013","unstructured":"Gilron I, Jensen TS, Dickenson AH. Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol. 2013;12:1084\u201395.","journal-title":"Lancet Neurol"},{"key":"1071_CR11","doi-asserted-by":"crossref","unstructured":"Bennett MI, Backonja MM, Baron R, Bouhassira D, Freynhagen R, Scholz J, Tolle TR, Wittchen H-U, Jensen TS. Using screening tools to identify neuropathic pain. Pain 2007;127:199\u2013203","DOI":"10.1016\/j.pain.2006.10.034"},{"key":"1071_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807\u201319.","journal-title":"Lancet Neurol"},{"key":"1071_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cns.12099","volume":"19","author":"G Mion","year":"2013","unstructured":"Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013;19:370\u201380.","journal-title":"CNS Neurosci Ther"},{"key":"1071_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-00897-0","volume":"10","author":"PR Shiroma","year":"2020","unstructured":"Shiroma PR, Thuras P, Wels J, Albott CS, Erbes C, Tye S, Lim KO. A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression. Transl Psychiatry. 2020;10:1\u20139.","journal-title":"Transl Psychiatry"},{"key":"1071_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.599721","volume":"11","author":"C Culp","year":"2020","unstructured":"Culp C, Kim HK, Abdi S. Ketamine use for cancer and chronic pain management. Front Pharmacol. 2020;11: 599721.","journal-title":"Front Pharmacol"},{"key":"1071_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpsychires.2014.12.012","volume":"61","author":"K Xu","year":"2015","unstructured":"Xu K, Krystal JH, Ning Y, et al. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia. J Psychiatr Res. 2015;61:64\u201372.","journal-title":"J Psychiatr Res"},{"key":"1071_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/j.1526-4637.2007.00402.x","volume":"9","author":"R-T Kiefer","year":"2008","unstructured":"Kiefer R-T, Rohr P, Ploppa A, Dieterich H-J, Grothusen J, Koffler S, Altemeyer K-H, Unertl K, Schwartzman RJ. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med Malden Mass. 2008;9:1173\u2013201.","journal-title":"Pain Med Malden Mass"},{"key":"1071_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40264-021-01120-9","volume":"44","author":"S Cotter","year":"2021","unstructured":"Cotter S, Wong J, Gada N, Gill R, Jones SC, Chai G, Foster D, Avigan M, Mundkur M. Repeated or continuous medically supervised ketamine administration associated with hepatobiliary adverse events: a retrospective case series. Drug Saf. 2021;44:1365\u201374.","journal-title":"Drug Saf"},{"key":"1071_CR19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/ALN.0b013e3181b437b1","volume":"111","author":"M Sigtermans","year":"2009","unstructured":"Sigtermans M, Dahan A, Mooren R, Bauer M, Kest B, Sarton E, Olofsen E. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Anesthesiology. 2009;111:892\u2013903.","journal-title":"Anesthesiology"},{"key":"1071_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0006-3223(97)00556-8","volume":"43","author":"CM Adler","year":"1998","unstructured":"Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry. 1998;43:811\u20136.","journal-title":"Biol Psychiatry"},{"key":"1071_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bcp.12094","volume":"77","author":"M Niesters","year":"2014","unstructured":"Niesters M, Martini C, Dahan A. Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol. 2014;77:357\u201367.","journal-title":"Br J Clin Pharmacol"},{"key":"1071_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/cns.12072","volume":"19","author":"S Marland","year":"2013","unstructured":"Marland S, Ellerton J, Andolfatto G, Strapazzon G, Thomassen O, Brandner B, Weatherall A, Paal P. Ketamine: use in anesthesia. CNS Neurosci Ther. 2013;19:381\u20139.","journal-title":"CNS Neurosci Ther"},{"key":"1071_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7205\/MILMED.171.6.484","volume":"171","author":"GT Guldner","year":"2006","unstructured":"Guldner GT, Petinaux B, Clemens P, Foster S, Antoine S. Ketamine for procedural sedation and analgesia by nonanesthesiologists in the field: a review for military health care providers. Mil Med. 2006;171:484\u201390.","journal-title":"Mil Med"},{"key":"1071_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/ALN.0000000000003743","volume":"134","author":"GS Murphy","year":"2021","unstructured":"Murphy GS, Avram MJ, Greenberg SB, Benson J, Bilimoria S, Maher CE, Teister K, Szokol JW. Perioperative methadone and ketamine for postoperative pain control in spinal surgical patients: a randomized, double-blind, placebo-controlled trial. Anesthesiology. 2021;134:697\u2013708.","journal-title":"Anesthesiology"},{"key":"1071_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1213\/ANE.0000000000004185","volume":"129","author":"V Orhurhu","year":"2019","unstructured":"\u2022 Orhurhu V, Orhurhu MS, Bhatia A, Cohen SP. Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2019;129:241\u201354. This study provides a in-depth look at the use of ketamine in the treatment of neuropathic pain and the outcomes of these studies. Most data supports short-term benefit with ketamine use for neuropathic pain.","journal-title":"Anesth Analg"},{"key":"1071_CR26","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/jcph.1920","volume":"61","author":"ES Schwenk","year":"2021","unstructured":"Schwenk ES, Torjman MC, Moaddel R, Lovett J, Katz D, Denk W, Lauritsen C, Silberstein SD, Wainer IW. Ketamine for refractory chronic migraine: an observational pilot study and metabolite analysis. J Clin Pharmacol. 2021;61:1421\u20139.","journal-title":"J Clin Pharmacol"},{"key":"1071_CR27","doi-asserted-by":"publisher","first-page":"952","DOI":"10.5811\/westjem.2018.8.37875","volume":"19","author":"AR Etchison","year":"2018","unstructured":"Etchison AR, Bos L, Ray M, McAllister KB, Mohammed M, Park B, Phan AV, Heitz C. Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial. West J Emerg Med. 2018;19:952\u201360.","journal-title":"West J Emerg Med"},{"key":"1071_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/09699260.2021.1922146","volume":"30","author":"MT Provido-Aljibe","year":"2022","unstructured":"Provido-Aljibe MT, Yee CM, Low ZJC, Hum A. The impact of a standardised ketamine step protocol for cancer neuropathic pain. Prog Palliat Care. 2022;30:4\u201310.","journal-title":"Prog Palliat Care"},{"key":"1071_CR29","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/jamaoncol.2018.0131","volume":"4","author":"MT Fallon","year":"2018","unstructured":"Fallon MT, Wilcock A, Kelly CA, Paul J, Lewsley L-A, Norrie J, Laird BJA. Oral ketamine vs placebo in patients with cancer-related neuropathic pain: a randomized clinical trial. JAMA Oncol. 2018;4:870\u20132.","journal-title":"JAMA Oncol"},{"key":"1071_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.bpa.2017.05.005","volume":"31","author":"J-P Estebe","year":"2017","unstructured":"Estebe J-P. Intravenous lidocaine. Best Pract Res Clin Anaesthesiol. 2017;31:513\u201321.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"1071_CR31","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.112290","volume":"10","author":"J Tully","year":"2021","unstructured":"Tully J, Jung JW, Patel A, et al. Utilization of intravenous lidocaine infusion for the treatment of refractory chronic pain. Anesthesiol Pain Med. 2021;10: e112290.","journal-title":"Anesthesiol Pain Med"},{"key":"1071_CR32","doi-asserted-by":"crossref","unstructured":"Gupta H, Patel A, Eswani Z, Moore P, Steib M, Lee C, Kaye AD. Role of Intravenous Lidocaine Infusion in the Treatment of Peripheral Neuropathy. Orthop Rev. 13:25567","DOI":"10.52965\/001c.25567"},{"key":"1071_CR33","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12630-019-01395-8","volume":"66","author":"DE Moulin","year":"2019","unstructured":"Moulin DE, Morley-Forster PK, Pirani Z, Rohfritsch C, Stitt L. Intravenous lidocaine in the management of chronic peripheral neuropathic pain: a randomized-controlled trial. Can J Anaesth J Can Anesth. 2019;66:820\u20137.","journal-title":"Can J Anaesth J Can Anesth"},{"key":"1071_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/AAP.0000000000000741","volume":"43","author":"Y-C Kim","year":"2018","unstructured":"Kim Y-C, Casta\u00f1eda AM, Lee C-S, Jin H-S, Park KS, Moon JY. Efficacy and safety of lidocaine infusion treatment for neuropathic pain: a randomized, double-blind, and placebo-controlled study. Reg Anesth Pain Med. 2018;43:415\u201324.","journal-title":"Reg Anesth Pain Med"},{"key":"1071_CR35","doi-asserted-by":"crossref","unstructured":"Zhu B, Zhou X, Zhou Q, Wang H, Wang S, Luo K.\u00a0Intra-venous lidocaine to relieve neuropathic pain: a systematic review and meta-analysis. Front. Neurol. 2019;10.","DOI":"10.3389\/fneur.2019.00954"},{"key":"1071_CR36","unstructured":"Hicks MA, Tyagi A.\u00a0Magnesium Sulfate. StatPearls. 2022."},{"key":"1071_CR37","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/nu10060730","volume":"10","author":"AE Kirkland","year":"2018","unstructured":"Kirkland AE, Sarlo GL, Holton KF. The role of magnesium in neurological disorders. Nutrients. 2018;10:730.","journal-title":"Nutrients"},{"key":"1071_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40263-019-00618-2","volume":"33","author":"D Kreutzwiser","year":"2019","unstructured":"Kreutzwiser D, Tawfic QA. Expanding role of NMDA receptor antagonists in the management of pain. CNS Drugs. 2019;33:347\u201374.","journal-title":"CNS Drugs"},{"key":"1071_CR39","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.3390\/nu12082184","volume":"12","author":"H-J Shin","year":"2020","unstructured":"Shin H-J, Na H-S, Do S-H. Magnesium and pain. Nutrients. 2020;12:2184.","journal-title":"Nutrients"},{"key":"1071_CR40","volume":"11","author":"I Urits","year":"2021","unstructured":"Urits I, Jung JW, Amgalan A, et al. Utilization of magnesium for the treatment of chronic pain. Anesthesiol Pain Med. 2021;11: e112348.","journal-title":"Anesthesiol Pain Med"},{"key":"1071_CR41","doi-asserted-by":"crossref","unstructured":"Soleimanpour H, Imani F, Dolati S, Soleimanpour M, Shahsavarinia K.\u00a0Management of pain using magnesium sulphate: a narrative review. Postgrad Med. 2022;1\u20137.","DOI":"10.1080\/00325481.2022.2035092"},{"key":"1071_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/ALN.0000000000003345","volume":"133","author":"G Pickering","year":"2020","unstructured":"\u2022\u2022 Pickering G, Pereira B, Morel V, et al. Ketamine and magnesium for refractory neuropathic pain: a randomized, double-blind, crossover trial. Anesthesiology. 2020;133:154\u201364. This article evaluates the role of magnesium in the treatment of neuropathic pain with comparative data to ketamine.","journal-title":"Anesthesiology"},{"key":"1071_CR43","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/pme.12081","volume":"14","author":"G Xu","year":"2013","unstructured":"Xu G, Lv Z-W, Feng Y, Tang W-Z, Xu G. A single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia. Pain Med. 2013;14:884\u201394.","journal-title":"Pain Med"},{"key":"1071_CR44","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3390\/nu12082221","volume":"12","author":"T Julian","year":"2020","unstructured":"Julian T, Syeed R, Glascow N, Angelopoulou E, Zis P. B12 as a treatment for peripheral neuropathic pain: a systematic review. Nutrients. 2020;12:2221.","journal-title":"Nutrients"},{"key":"1071_CR45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.2169\/internalmedicine.38.472","volume":"38","author":"S Kuwabara","year":"1999","unstructured":"Kuwabara S, Nakazawa R, Azuma N, Suzuki M, Miyajima K, Fukutake T, Hattori T. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med. 1999;38:472\u20135.","journal-title":"Intern Med"},{"key":"1071_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ctim.2018.10.014","volume":"41","author":"JY Wang","year":"2018","unstructured":"Wang JY, Wu YH, Liu SJ, Lin YS, Lu PH. Vitamin B12 for herpetic neuralgia: a meta-analysis of randomised controlled trials. Complement Ther Med. 2018;41:277\u201382.","journal-title":"Complement Ther Med"},{"key":"1071_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3344\/kjp.2018.31.3.183","volume":"31","author":"A Sil","year":"2018","unstructured":"Sil A, Kumar H, Mondal RD, Anand SS, Ghosal A, Datta A, Sawant SV, Kapatkar V, Kadhe G, Rao S. A randomized, open labeled study comparing the serum levels of cobalamin after three doses of 500 mcg vs. a single dose methylcobalamin of 1500 mcg in patients with peripheral neuropathy. Korean J Pain. 2018;31:183\u201390.","journal-title":"Korean J Pain"},{"key":"1071_CR48","doi-asserted-by":"crossref","unstructured":"X\u01d4 G, Xu S, Tang W-Z, X\u00fa G, Cheng C, Xu J.\u00a0Local injection of methylcobalamin combined with lidocaine for acute herpetic neuralgia. Pain Med. 2015;pnv005","DOI":"10.1093\/pm\/pnv005"},{"issue":"Suppl 5","key":"1071_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/09637480802406153","volume":"60","author":"A Talaei","year":"2009","unstructured":"Talaei A, Siavash M, Majidi H, Chehrei A. Vitamin B12 may be more effective than nortriptyline in improving painful diabetic neuropathy. Int J Food Sci Nutr. 2009;60(Suppl 5):71\u20136.","journal-title":"Int J Food Sci Nutr"},{"key":"1071_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.11622\/smedj.2016027","volume":"57","author":"B Jayabalan","year":"2016","unstructured":"Jayabalan B, Low L. Vitamin B supplementation for diabetic peripheral neuropathy. Singapore Med J. 2016;57:55\u20139.","journal-title":"Singapore Med J"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01071-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-022-01071-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01071-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T10:30:13Z","timestamp":1662028213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-022-01071-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1007\/s11916-022-01071-5","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"26 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Preston R. McMullin, Mohammed Ahnaf Arefin, Alexander Thomas Hynes, Moawiz Saeed, Sarvani Gandhavadi, and Nuha Arefin declare no conflict of interest. Maxim S. Eckmann, reports as a technical consultant for AVANOS and Abbott, funded research through SPR Therapeutics, and Education Grants from Medtronic, Boston Scientific, Abbott.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}